CIGI NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Colliers International Group Inc Bats · Real Estate · Real Estate Services

Open interactive chart View report data Download investor PDF
Latest close 97.49 USD
-4.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -12.1% below the Trend Line and sits at 11.1% of its 52-week range. The latest completed week returned -4.3%, after a 5.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 0d.

Setup score 38 out of 100
Latest Close 97.49 USD 24 Jul 2026
1W Return -4.3% latest completed week
4W Return 5.3% short-term follow-through
12W Return -5.8% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 56.43% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.3% Latest completed week; four-week move 5.3%. Indicator stack 18/92 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.43% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 59/100 conviction; expected move 13.7%. News sentiment 52/100 51 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -12.1% below the Trend Line and sits at 11.1% of its 52-week range. The latest completed week returned -4.3%, after a 5.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0512-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.3% over four weeks, -5.8% over 12 weeks, and -31.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.3%
4W5.3%
12W-5.8%
26W-30.3%
52W-31.5%
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.41Latest activity-pressure read.
Pressure change438.4%Four-week change in activity pressure.
Leadership-32.00Latest relative-leadership reading.
RS change19.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality28/100Profitability and accounting quality. Underlying universe rank 73; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework39/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
58.8x
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
13.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
24.5%
Gross profit retained from each unit of revenue.
Operating margin
6.9%
Operating profit retained from revenue.
Free-cash-flow margin
5.1%
Free cash flow generated from revenue.
Return on invested capital
7.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
17.3%
Latest one-year revenue growth.
EPS growth
-41.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-29.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.3%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CIGI shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of n/a, expected move of 13.7%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move13.7%
Put/call volume
Pressure-100
Speculation0
Volatility77
Trend agreement37
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 51 relevant articles.

10 positive · 36 neutral · 5 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move13.7%Nearest-chain priced movement where available.
52-week drawdown-43.1%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+7.7%Week of 3 Apr.
Worst week-18.8%Week of 13 Feb.
Latest week-4.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses5
Sharp losses9
Recent vol4.3%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis16/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.05; No reversal markers Next-Week ExpectancyPositive 56.43%

Next-week expectancy is positive with a 56.43% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 56; Small Cap Core rank 81 SVQF39/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 444.5 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options48/100

CIGI shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of n/a, expected move of 13.7%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 13.7% Sentiment52/100

Weighted news tone is neutral across 51 relevant articles.

Colliers International Group Inc (CIGI) Dividends & Stock Splits: Historical Payouts and Event Timeline Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202697.49 USD-4.3%110.9 USD125.3 USD0.41-32.001.1MOff
17 Jul 2026101.9 USD4.4%112.6 USD125.3 USD0.42-30.75968.5KOff
10 Jul 202697.64 USD-0.9%114.1 USD125.3 USD0.18-36.991.1MOff
3 Jul 202698.51 USD6.4%115.7 USD125.4 USD0.06-35.901.1MOff
26 Jun 202692.60 USD1.6%117.3 USD125.4 USD-0.12-39.781.6MOff
19 Jun 202691.16 USD-6.2%119.0 USD125.4 USD-0.28-43.92789.1KOff
12 Jun 202697.23 USD0.2%120.6 USD125.4 USD-0.29-39.23825.2KOff
5 Jun 202697.00 USD3.0%122.3 USD125.4 USD-0.40-38.55785.4KOff
29 May 202694.21 USD-1.8%124.1 USD125.4 USD-0.48-43.50897.9KOff
22 May 202695.92 USD4.4%126.3 USD125.5 USD-0.54-41.331.2MOff
15 May 202691.85 USD-6.7%128.6 USD125.4 USD-0.65-43.603.4MOff
8 May 202698.47 USD-4.8%130.8 USD125.5 USD-0.68-40.311.7MOff
1 May 2026103.5 USD-4.9%132.5 USD125.4 USD-0.84-34.46893.7KOff
24 Apr 2026108.8 USD-7.0%134.2 USD125.3 USD-1.08-30.56761.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.